Tamponade is a grave complication of PCI.
Results:
Tamponade occurred in 0.11% of all PCI patients (pts) but 36% of pts with CP. Group A pts were more likely to have a history of stroke (p=0.051). Pts with previous CABG experienced less tamponade (p=0.001). Use of 2b3a inhibitors and bivalirudin was similar between the two groups. VT occurred more often in group A (p=0.02). More pts in group A underwent elective PCI (p=0.04). Anatomic characteristics (lesion class, CTO, vessel tortuosity, calcification etc), use of atheroablative devices, PTFE stents, and need for cardiac surgery were similar in the two groups. In group A coil embolization was used more often (p=0.003). Unadjusted rates of in-hospital death and death throughout the study period were similar.
A multivariate model was developed to adjust for differences between the groups (table) . After adjustment, pts experiencing tamponade had a greater than 3 fold higher probability for death (OR=3.34) in the study period. Pts that underwent elective PCI were 73 % less likely to die (OR=0.27).
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